Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: BSE India
  • Sector: Materials
  • Industry: Chemicals
  • Sub-Industry: Basic & Diversified Chemicals

Dai-Ichi Karkaria Ltd

+ Add to Watchlist

DIK:IN

182.10 INR 7.50 3.96%

As of 05:25:36 ET on 01/30/2015.

Snapshot for Dai-Ichi Karkaria Ltd (DIK)

Open: 188.50 Day's Range: 178.10 - 188.50 Volume: 7,295
Previous Close: 189.60 52wk Range: 47.32 - 210.00 1-Yr Rtn: +258.79%

Stock Chart for DIK

No chart data available.
  • DIK:IN 182.10
  • 1D
  • 1M
  • 1Y
189.60
Interactive DIK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DIK

Current P/E Ratio (ttm) 8.6963
Estimated P/E(-) -
Relative P/E vs. SENSEX 0.4287
Earnings Per Share (ttm) 20.9400
Est. EPS -
Est. PEG Ratio -
Market Cap (M INR) 1,356.87
Shares Outstanding (M) 7.45
30 Day Average Volume 14,718
Price/Book (mrq) 1.9479
Price/Sale (ttm) 0.9206
Dividend Indicated Gross Yield 1.10%
Cash Dividend (INR) 2.0000
Dividend Ex-Date 07/30/2014
5 Year Dividend Growth 5.64%
Next Earnings Announcement 04/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DIK

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for DIK

Dai-Ichi Karkaria Limited develops textile additives, spin finishes, textile softeners, antistat agents and defoamers for acrylic fibres. They also develop bulk drugs and fine chemicals for a number of therapeutic areas, including cardiovascular, antihistaminics, analgesics, anxiolytic, antidepressant and anticonsulgants.

Shernaz Firoze VakilChairman/Managing DirectorKavita ThadeshwarSecretary
Nitin NimkarController
More Company Profile & Key Executives for DIK

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil